Compass Pathways plc is a pioneering mental health care company focused on developing innovative psychedelic therapies, notably leveraging psilocybin, to address significant unmet needs in the treatment of mental health conditions. Headquartered in Cheshire, UK, the firm is engaged in rigorous clinical research in both the UK and US, primarily targeting treatment-resistant depression. Through its dedication to advancing research and fostering transformative therapies, Compass Pathways aims to redefine mental health care standards and improve patient outcomes worldwide, positioning itself as a leader in the emerging field of psychedelic-assisted therapy. Show more

Location: 33 BROADWICK STREET, LONDON, UNITED KINGDOM, W1F 0DQ, London, W1F 0DQ, USA | Website: https://compasspathways.com | Industry: MEDICAL CARE FACILITIES | Sector: HEALTHCARE


Market Cap

642.4M

52 Wk Range

$2.25 - $8.20

Previous Close

$6.79

Open

$6.77

Volume

1,015,654

Day Range

$6.49 - $6.85

Enterprise Value

491.6M

Cash

185.9M

Avg Qtr Burn

-35.11M

Insider Ownership

12.12%

Institutional Own.

62.06%

Qtr Updated

09/30/25